📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. (2019)

First Author: Sale MJ
Attributed to:  How does ERK1/2-dependent phosphorylation target BimEL to the proteasome? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-12409-w

PubMed Identifier: 31727888

Publication URI: http://europepmc.org/abstract/MED/31727888

Type: Journal Article/Review

Volume: 10

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723